Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

The Hidden Strength of Active Sector ETFs Spiking Right Now

BY | ETF Database
6:41 am ET 08/17/26 | 16 VIEWS
Sector ETFs have long been a part of the overall ETF ecosystem. The ETF’s transparency, flexibility, and tax efficiency have made it a vehicle for all sorts of sector strategies. However, they haven’t always delivered. Adding active management may unlock the sector ETF’s potential, as displayed in funds like the T. Rowe Price Health Care ETF (TMED ).Key Takeaways: Sector ETFs have been a big part of the ETF ecosystem for years, with a wide range of funds. T. Rowe Price’s Health Care ETF (TMED) asks 44 basis point (bps) and represents a strong use case for active therein. The strategy can leverage active flexibility across multiple segments in health care, and has returned 49.1% over the last year. TMED charges a 44-bps fee to actively invest in health care stocks from around the world. Leaning on T. Rowe Price’s fundamental research capabilities, the strategy actively invests in health care firms, from pharmaceuticals to biotech to health care service firms. Specifically, the strategy applies a bottom-up approach, using both growth and value strategies to identify 100–150 stocks. TMED primarily invests in companies within the MSCI GICS health care sector. Together, that has helped the active strategy return some 19% YTD, and 49.1% over the last 12 months, per ETF Database data. Per T. Rowe Price data, the strategy uses the S&P Health Care Select Sector Index as its benchmark. TMED has outperformed that index over both time frames, with the latter returning 8% and 28.2%, respectively. Where TMED may outperform other sector ETFs, however, is its active approach. Many sector ETFs follow small, very specific indexes, offering particularly niche exposures that can be volatile. For those sectors that are broader, meanwhile, passive approaches expose them to greater volatility. See more: Top Active ETF TCAF Spikes After Milestone en Route to $10 Billion TMED represents something else. With its active remit and flexibility, the strategy isn’t just limited to biotech or pharma. Its managers use that fundamental, bottom-up approach to find the best firms in healthcare overall. Active sector ETFs take a theme and follow it where it leads, making such funds potentially strong satellite options in ETFs right now and in the future. As uncertainty grows and investors look for outperformance and diversification from concentration risk, that strength could really prove itself an important one. For more news, information, and analysis, visit our Active ETF Content Hub.

More Commentary

AI Infrastructure Trade Still Alive. Seize It with SOXL
BY | ETF Database
7:10 am ET 08/17/26 | 15 VIEWS
Small-Caps, Big Opportunities: Consider Value Amid Rally
BY | ETF Database
6:26 am ET 08/17/26 | 23 VIEWS
Free Cash Flow ETFs: How VictoryShares Matches FCF Strategies to Advisor and Client Needs
BY | ETF Database
08/14/2026 | 67 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.